Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to IMNM. [ FAQ on what and how to ask] For non-IMNM questions, click the logo in the upper-right corner to return to the main page and ask there.
Unlock YouTube Video by Subscribing to iPick.ai Premium!
Not available
Address: 18702 North Creek Parkway, Suite 100, Bothell, WA, United States, 98011
Employees: 247
Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
Chairman, President & CEO
Chief Financial Officer
Chief Medical Officer
Chief Technical Officer
Chief Scientific Officer
Chief Legal Officer, General Counsel & Corporate Secretary
Executive Vice President of Commercial
My Watchlist
